Literature DB >> 16598603

Home Monitoring: what can we expect in the future?

J-C Deharo1, P Djiane.   

Abstract

The Home Monitoring of implanted cardiac rhythm management devices developed by Biotronik (Berlin, Germany) is a new useful tool for monitoring patients. Home Monitoring provides access to technical and clinical data, allowing almost continuous patient surveillance. The implanted defibrillators and pacemakers transmit encrypted messages, which are automatically analyzed in the Home Monitoring Service Center and sent to the physician. The expected benefit of this kind of data transmission is an improvement in patient follow-up and early detection of changes in the rhythmologic state of the patient. However, these new tools raise several questions, which will require an answer in the nearest future. These questions focus on safety and economic aspects, and on the liability of the physician and the manufacturer. Technological improvement is also expected.

Entities:  

Mesh:

Year:  2006        PMID: 16598603     DOI: 10.1007/s00392-006-1307-5

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  4 in total

1.  The value of permanent follow-up of implantable pacemakers--first results of an European trial.

Authors:  K Wallbrück; C Stellbrink; M Santini; J Gill; A Hartmann; E Wunderlich
Journal:  Biomed Tech (Berl)       Date:  2002       Impact factor: 1.411

Review 2.  [The place of telemedicine in rhythmology and cardiac pacing].

Authors:  D Lamaison; P Motreff; F Jean; E Geoffroy; R Rodriguez; G Souteyrand; S Chanseaume; S Terrazoni; J Cassagnes
Journal:  Arch Mal Coeur Vaiss       Date:  2004-11

3.  Potential cost savings by telemedicine-assisted long-term care of implantable cardioverter defibrillator recipients.

Authors:  Laurent Fauchier; Nicolas Sadoul; Claude Kouakam; Florent Briand; Michel Chauvin; Dominique Babuty; Jacques Clementy
Journal:  Pacing Clin Electrophysiol       Date:  2005-01       Impact factor: 1.976

Review 4.  Home monitoring in ICD therapy: future perspectives.

Authors:  D A M J Theuns; J C J Res; L J Jordaens
Journal:  Europace       Date:  2003-04       Impact factor: 5.214

  4 in total
  6 in total

Review 1.  Advances in remote monitoring of implantable pacemakers, cardioverter defibrillators and cardiac resynchronization therapy systems.

Authors:  Werner Jung; Andreas Rillig; Ralf Birkemeyer; Tomislav Miljak; Udo Meyerfeldt
Journal:  J Interv Card Electrophysiol       Date:  2008-09-27       Impact factor: 1.900

2.  Activation of remote monitoring for cardiac implantable electronic devices: small dog for tall weeds.

Authors:  Giuseppe D'Ancona; Erdal Safak; Jochen Senges; Matthias Hochadel; Van Luyen Nguyen; Christian Perings; Werner Jung; Stefan Spitzer; Lars Eckardt; Johannes Brachmann; Karlheinz Seidl; Hans Ulrich Hink; Hüseyin Ince; Jasmin Ortak
Journal:  Clin Res Cardiol       Date:  2017-06-07       Impact factor: 5.460

3.  Patient satisfaction and suggestions for improvement of remote ICD monitoring.

Authors:  Helen Høgh Petersen; Mie Christa Jensen Larsen; Olav Wendelboe Nielsen; Finn Kensing; Jesper Hastrup Svendsen
Journal:  J Interv Card Electrophysiol       Date:  2012-03-15       Impact factor: 1.900

4.  "Home monitoring" for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study.

Authors:  Melanie Hauck; Alexander Bauer; Frederik Voss; Slawomir Weretka; Hugo A Katus; Ruediger Becker
Journal:  Clin Res Cardiol       Date:  2008-09-05       Impact factor: 5.460

5.  Remote monitoring of implantable cardioverter defibrillator patients: a safe, time-saving, and cost-effective means for follow-up.

Authors:  M J Pekka Raatikainen; Paavo Uusimaa; Mireille M E van Ginneken; Jacques P G Janssen; Markku Linnaluoto
Journal:  Europace       Date:  2008-08-14       Impact factor: 5.214

6.  Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial.

Authors:  Franck Halimi; Jacques Clémenty; Patrick Attuel; Xavier Dessenne; Walid Amara
Journal:  Europace       Date:  2008-09-04       Impact factor: 5.214

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.